Boston Scientific to acquire approximately 64% of MITech for approximately $230 million Boston Scientific to acquire approximately 64% of...
Drugs
PD-1 immune combination therapy advances to first-line treatment of gastric cancer PD-1 immune combination therapy advances to first-line treatment of...
Roche Aβ monoclonal antibody Crenezumab failed again in clinical trials for Alzheimer's disease Roche Aβ monoclonal antibody Crenezumab failed...
UK MHRA accepts marketing application for almetinib UK MHRA accepts marketing application for almetinib. On June 14, EQRx, Inc...
Pfizer COVID-19 oral drug Paxlovid: One Phase II/III clinical trial failed Pfizer COVID-19 oral drug Paxlovid: One Phase II/III...
FDA approves Alnylam's RNAi therapy Amvuttra FDA approves Alnylam's RNAi therapy Amvuttra. On June 13, Alnylam announced that the...
Most promising breakthroughs: Drug candidate for breast cancer will start clinical trials Most promising breakthroughs: Drug candidate for breast...
More than 500 new drugs for blood diseases are in development. More than 500 new drugs for blood diseases...
Amylyx's ALS drug gets conditional approval in Canada Amylyx's ALS drug gets conditional approval in Canada. The first in...
FDA approves oral JAK inhibitor baricitinib for the treatment of alopecia areata FDA approves oral JAK inhibitor baricitinib for...
Innovative treatment for childhood brain tumors: Phase II trials of Tovorafenib is successful Innovative treatment for childhood brain tumors:...
Canadian regulator approves Albrioza to launch innovative approach to ALS Canadian regulator approves Albrioza to launch innovative approach to...
2022 Top 50 global pharmaceutical companies 2022 Top 50 global pharmaceutical companies The US Pharmaceutical Executive "Pharmaceutical Manager"...
First time: Clinical cure of solid tumor archived only by drugs First time: Clinical cure of solid tumor archived...
FDA panel unanimously backs bluebird gene therapy FDA panel unanimously backs bluebird gene therapy. On June 11, bluebird...
FGFR inhibitors demonstrate efficacy in 14 cancer types FGFR inhibitors demonstrate efficacy in 14 cancer types. Janssen, a Johnson &...
AHS 2022: AbbVie Biohaven Teva announce latest researches on migraine drugs AHS 2022: AbbVie Biohaven Teva announce latest researches on migraine drugs. ...
2008-2021: U.S. new drug listing prices rose nearly 90 times 2008-2021: U.S. new drug listing prices rose nearly 90...
Rigel shares fall 60% after Syk inhibitor fostamatinib phase III study fails Rigel shares fall 60% after Syk inhibitor...
Astellas anemia drug Evrenzo gets backing from UK NICE after FDA rejection.fter FDA rejection Astellas anemia drug Evrenzo gets...
The look back at new drugs approved by FDA in 2021 The look back at new drugs approved by...
The first oral medicine for severe COVID-19: Veru submits sabizabulin EUA to FDA The first oral medicine for severe...
The world's first CD20/CD3 double antibody was approved by EU The world's first CD20/CD3 double antibody was approved by...
Why breast cancer classification and treatment may be about to change? On June 5, 2022, AstraZeneca and Daiichi Sankyo...
BMS agrees to settle $11 million settlement amid accusations of hindering HIV generics competition BMS agrees to settle $11...
Tirzepatide will be used for weight loss: Potential market with 10 billion US dollars Tirzepatide will be used for...
Pfizer Lbrance and Gilead Trodelvy: Trial data are disappointing Pfizer Lbrance and Gilead Trodelvy: Trial data are disappointing. Recently,...
New ADC Reduce risks of advanced breast cancer disease progression by 50% New ADC Reduce risks of advanced breast...
1.1 billion US dollars: Regeneron buys cancer drug from Sanofi 1.1 billion US dollars: Regeneron buys cancer drug from...
Why didn't some lifelong smokers get lung cancer? Why didn't some lifelong smokers get lung cancer? Scientists may have discovered...
